https://www.theaustralian.com.au/business/dataroom/agl-could-return-for-another-crack-at-vocus/news-story/f253e2a60ea08de3e2275dd6ce7c0174Not sure if it's a quiet news day but explains the gap this morning.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%